Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Cetuximab of cisplatine bij HPV-positief hoofd-halscarcinoom?
feb 2019 | Hoofd-halsoncologie, Radiotherapie